
Opinion|Videos|August 23, 2024
Exciting Developments With Subcutaneous Biologics
Author(s)Jennifer Seminerio, MD
A leading gastroenterologist highlights her initial thoughts about subcutaneous biologics.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What about subcutaneous biologics excited you the most when they came out? What were your main concerns?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Lipfendra, first oral PCSK9 inhibitor
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Capital Rx is now Judi Rx in a company rebrand
4
FTC secures settlement with Caremark, locks in up to $8.5 billion in consumer savings
5





























